Sanuwave Health's Preliminary Q2 Revenue Tops Revised Guidance
Sanuwave Health (SNWV) said Monday Q2 revenue is now expected to be $9.6 million to $9.8 million, above the high end of its revised guidance of $8.5 million to $9.5 million. The preliminary revenue range represents a 3% to 5% decline from $10.1 million reported in Q2 a year earlier, according to a statement. The company said it expects to report full Q2 results in August.
Sanuwave Health (SNWV) said Monday Q2 revenue is now expected to be $9.6 million to $9.8 million, above the high end of its revised guidance of $8.5 million to $9.5 million.
The preliminary revenue range represents a 3% to 5% decline from $10.1 million reported in Q2 a year earlier, according to a statement.
The company said it expects to report full Q2 results in August.